Peptidoglycan precursors

Peptidoglycan precursors are essential metabolic intermediates required for the assembly of the bacterial cell wall, a complex polymer that provides structural integrity and protects the cell from osmotic lysis (StatPearls, 2023). The most critical precursor targeted by antibiotics is Lipid II, which consists of a disaccharide-pentapeptide unit linked to a long-chain undecaprenyl lipid carrier (Nature Reviews Microbiology, 2013). During cell wall synthesis, these precursors are transported across the cytoplasmic membrane and incorporated into the existing peptidoglycan meshwork by transglycosylases and transpeptidases (PubMed, PMID: 18641657). Many potent antibiotics, such as glycopeptides (e.g., vancomycin), exert their bactericidal effects by binding directly to these precursors, particularly the D-alanyl-D-alanine terminus, thereby sterically hindering the enzymes responsible for cross-linking (NIH, 2022). Because the peptidoglycan biosynthetic pathway is unique to prokaryotes and absent in human cells, these precursors serve as highly selective and effective targets for treating a wide range of Gram-positive bacterial infections (Journal of Biological Chemistry, 2019). Disruption of these precursors leads to a weakened cell wall, resulting in bacterial cell death through osmotic rupture.

Other names

Lipid IILipid IMurein precursorsUDP-N-acetylmuramyl-pentapeptideUndecaprenyl-pyrophosphate-linked precursors

Inhibition of cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors (e.g., Lipid II) to block transglycosylation and transpeptidation (StatPearls, 2023), or by inhibiting the dephosphorylation of undecaprenyl pyrophosphate to prevent the recycling of the lipid carrier (PubMed, PMID: 15590775).